RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT
2015-01-01 Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M.
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT
2015-01-01 Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M.
Age-Dependent Influence of TNF-{alpha} Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients
2010-01-01 Buda, Gabriele; Martino, A; Orciuolo, E; Maggini, Valentina; Lapi, F; Galimberti, Sara; Barale, Roberto; Rossi, ANNA MARIA; Petrini, Mario
Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.
2009-01-01 Pelosini, M; Baronti, F; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Starita, A; Petrini, Mario
ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING A NON-MYELOABLATIVE (NMST) CONDITIONING WITH FLUDARABINE AND LOW DOSE TBI IN PATIENTS WITH HEMATOLOCICAL MALIGNANCIES AND METASTATIC MELANOMA: A SINGLE-CENTER EXPERIENCE.
2004-01-01 Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Azzarà, A; Carulli, Giovanni; Petrini, Mario
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS)
2018-01-01 Grassi, S; Palumbo, S; Mariotti, V; Ciabatti, E; Guerrini, F; Perutelli, F; Barate, C; Petrini, M; Pellegrini, S; Galimberti, S
Association in Outcome of Advanced Multiple Myeloma with Polymorphisms of Inflammatory-Related Genes IL-1A, IL-1B, IL1RN, TNF-a and TNFRSF1B.
2009-01-01 Buda, Gabriele; Martino, A; Orciuolo, E; Lupia, A; Galimberti, Sara; Gentile, M; Morabito, F; Rossi, ANNA MARIA; Petrini, Mario
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?
2013-01-01 L., Aprile; L., Puccetti; Galimberti, Sara; A., Gozzini; F., Scarpini; M., Defina; F., De Majo; C., Baratè; A., Sicuranza; V., Candi; B., Scappini; D., Raspadori; A., Gozzetti; A., Bosi; Petrini, Mario; M., Bocchia
ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT?
2014-01-01 Bocchia, M; Galimberti, Sara; Aprile, L; Gozzini, A; Santilli, F; Sicuranza, A; Abruzzese, E; Defina, M; Barate, C; Scappini, B.
AUTOIMMUNE DISEASES AND MYELOID HEMATOLOGICAL DISORDERS: A POSSIBLE PATHOGENETIC RELATIONSHIP
2020-01-01 Galimberti, S.; Baratè, C.; Ricci, F.; Balducci, S.; Governato, G.; Fulvio, G.; Elefante, E.; Ferro, F.; Di Paolo, A.; Baglietto, L.; Petrini, M.; Baldini, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT | 1-gen-2015 | Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M. | |
| ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT | 1-gen-2015 | Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M. | |
| Age-Dependent Influence of TNF-{alpha} Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients | 1-gen-2010 | Buda, Gabriele; Martino, A; Orciuolo, E; Maggini, Valentina; Lapi, F; Galimberti, Sara; Barale, Roberto; Rossi, ANNA MARIA; Petrini, Mario | |
| Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis. | 1-gen-2009 | Pelosini, M; Baronti, F; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Starita, A; Petrini, Mario | |
| ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING A NON-MYELOABLATIVE (NMST) CONDITIONING WITH FLUDARABINE AND LOW DOSE TBI IN PATIENTS WITH HEMATOLOCICAL MALIGNANCIES AND METASTATIC MELANOMA: A SINGLE-CENTER EXPERIENCE. | 1-gen-2004 | Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Azzarà, A; Carulli, Giovanni; Petrini, Mario | |
| Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) | 1-gen-2018 | Grassi, S; Palumbo, S; Mariotti, V; Ciabatti, E; Guerrini, F; Perutelli, F; Barate, C; Petrini, M; Pellegrini, S; Galimberti, S | |
| Association in Outcome of Advanced Multiple Myeloma with Polymorphisms of Inflammatory-Related Genes IL-1A, IL-1B, IL1RN, TNF-a and TNFRSF1B. | 1-gen-2009 | Buda, Gabriele; Martino, A; Orciuolo, E; Lupia, A; Galimberti, Sara; Gentile, M; Morabito, F; Rossi, ANNA MARIA; Petrini, Mario | |
| Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? | 1-gen-2013 | L., Aprile; L., Puccetti; Galimberti, Sara; A., Gozzini; F., Scarpini; M., Defina; F., De Majo; C., Baratè; A., Sicuranza; V., Candi; B., Scappini; D., Raspadori; A., Gozzetti; A., Bosi; Petrini, Mario; M., Bocchia | |
| ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT? | 1-gen-2014 | Bocchia, M; Galimberti, Sara; Aprile, L; Gozzini, A; Santilli, F; Sicuranza, A; Abruzzese, E; Defina, M; Barate, C; Scappini, B. | |
| AUTOIMMUNE DISEASES AND MYELOID HEMATOLOGICAL DISORDERS: A POSSIBLE PATHOGENETIC RELATIONSHIP | 1-gen-2020 | Galimberti, S.; Baratè, C.; Ricci, F.; Balducci, S.; Governato, G.; Fulvio, G.; Elefante, E.; Ferro, F.; Di Paolo, A.; Baglietto, L.; Petrini, M.; Baldini, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 129
- 1 Contributo su Rivista::1.5 Abst... 129
Data di pubblicazione
- 2010 - 2020 65
- 2000 - 2009 63
- 1996 - 1999 1
Rivista
- HAEMATOLOGICA 50
- BLOOD 45
- BONE MARROW TRANSPLANTATION 14
- HAEMATOLOGICA 8
- ANNALS OF THE RHEUMATIC DISEASES 3
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- BLOOD REVIEWS 2
- BONE MARROW TRANSPLANTATION 2
- ARTHRITIS AND RHEUMATISM 1
- LEUKEMIA RESEARCH 1
Keyword
- immune reconstitution 2
- immunotherapy 2
- T-lymphocytes 2
- AL-T 1
- ALL-T 1
- allogeneic stem cell transplant 1
- allogeneic stem cell transplantation 1
- allogeneic transplant 1
- Chronic Myeloid Leukemia 1
- immune surveillance 1
Lingua
- eng 79
Accesso al fulltext
- no fulltext 121
- open 5
- restricted 3